Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Barragán, Ana Maria"'
Autor:
Michiels, Steven, Barragán, Ana Maria, Souris, Kevin, Poels, Kenneth, Crijns, Wouter, Lee, John A., Sterpin, Edmond, Nuyts, Sandra, Haustermans, Karin, Depuydt, Tom
Publikováno v:
In Radiotherapy and Oncology July 2018 128(1):161-166
Publikováno v:
Kurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anaesthesiol. 2012;25(3):376-384. doi:10.1097/ACO.0b013e328352b4a8
Byrne K, Levins KJ, Buggy DJ. Les techniques d’anesthésie et d’analgésie lors d’une chirurgie de cancer primitif peuvent-elle affecter la récurrence ou la métastase? Can J Anesth. 2016;63(2):184-192. doi:10.1007/s12630-015-0523-8
Shapiro J, Jersky J, Katzav S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest. 1981;68(3):678-685. doi:10.1172/JCI110303
Puig N, Colluci D, Hernandez-Pando R. Influence of anaesthetic drugs on immune response: from inflammation to immunosuppression. OA Anaesth. 2013;1(3):21. https://www.oapublishinglondon.com/article/1091.
Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of Natural Killer Cell Activity and Promotion of Tumor Metastasis by Ketamine, Thiopental, and Halothane, but Not by Propofol: Mediating Mechanisms and Prophylactic Measures. Anesth Analg. 2003;97(5):1331-1339. doi:10.1213/01.ANE.0000082995.44040.07
Cho JS, Lee M-H, Kim S Il, et al. The Effects of Perioperative Anesthesia and Analgesia on Immune Function in Patients Undergoing Breast Cancer Resection: A Prospective Randomized Study. Int J Med Sci. 2017;14(10):970-976. doi:10.7150/ijms.20064
Al-Hasani R, Bruchas MR. Molecular Mechanisms of Opioid Receptor-Dependent Signalling and Behaviour. Anesthesiology. 2011;115(6):1363-1381. doi:10.1097/ALN.0b013e318238bba6.Molecular
Chen WK, Ren L, Wei Y, Zhu DX, Miao CH, Xu JM. General anesthesia combined with epidural anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression and facilitating intestinal functional recovery in colon cancer patients. Int J Colorectal Dis. 2015;30(4):475-481. doi:10.1007/s00384-014-2098-1
Borner C, Warnick B, Smida M, et al. Mechanisms of Opioid-Mediated Inhibition of Human T Cell Receptor Signaling. J Immunol. 2009;183(2):882-889. doi:10.4049/jimmunol.0802763
Wang J, Barke RA, Charboneau R, Loh HH, Roy S. Morphine negatively regulates interferon-γ promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem. 2003;278(39):37622-37631. doi:10.1074/jbc.M301224200
Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008;22(3):263-277. doi:10.1007/s00540-008-0626-2
Zhou Y, Li E, Li Y, Liu S. Attenuating sevoflurane-induced cellular injury of human peripheral lymphocytes by propofol in a concentration-dependent manner. Arch Pharm Res. 2011;34(9):1535-1543. doi:10.1007/s12272-011-0916-3
Wei H, Xie Z. Anesthesia, calcium homeostasis and Alzheimer’s disease. Curr Alzheimer Res. 2009;6(1):30-35. doi:10.2174/156720509787313934
Braz MG, Magalhães MR, Salvadori DM, et al. Evaluation of DNA damage and lipoperoxidation of propofol in patients undergoing elective surgery. Eur J Anaesthesiol. 2009;26(8):654-660. doi:10.1097/EJA.0b013e328329b12c
Rizzo MT. Cyclooxygenase-2 in oncogenesis. Clin Chim Acta. 2011;412(9-10):671-687. doi:10.1016/j.cca.2010.12.026
Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol. 2007;29(3-4):477-486. doi:10.1080/08923970701675085
Pirbudak Cocelli L, Ugur MG, Karadasli H. Comparison of Effects of Low-Flow Sevoflurane and Desflurane Anesthesia on Neutrophil and T-Cell Populations. Curr Ther Res-Clin Exp. 2012;73(1-2):41-51. doi:10.1016/j.curtheres.2012.02.005
Benish M, Bartal I, Goldfarb Y, et al. Perioperative use of β-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15(7):2042-2052. doi:10.1245/s10434-008-9890-5
Glasner A, Avraham R, Rosenne E, et al. Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor. J Immunol. 2010;184(5):2449-2457. doi:10.4049/jimmunol.0903301
Wang X, Liang Y, Wang J, Wang M. Effect of NS-398, a cyclooxygenase-2 selective inhibitor, on the cytotoxicity of cytotoxic T lymphocytes to ovarian carcinoma cells. Tumor Biol. 2013;34(3):1517-1522. doi:10.1007/s13277-013-0677-3
Veltman JD, Lambers MEH, van Nimwegen M, et al. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BMC Cancer. 2010;10:1-13. doi:10.1186/1471-2407-10-464
Lönnroth C, Andersson M, Arvidsson A, et al. Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer. Cancer Immun. 2008;8(February):1-10. doi:080206 [pii]
Ramirez MF, Tran P, Cata JP. The effect of clinically therapeutic plasma concentrations of lidocaine on natural killer cell cytotoxicity. Reg Anesth Pain Med. 2015;40(1):43-48. doi:10.1097/AAP.0000000000000191
Das J, Kumar S, Khanna S, Mehta Y. Are we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practice. J Anaesthesiol Clin Pharmacol. 2014;30(2):153. doi:10.4103/0970-9185.129996
Sacerdote P, Bianchi M, Gaspani L, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 2000;90(6):1411-1414. doi:10.1097/00000539-200006000-00028
Qi Y, Yao X, Zhang B, Du X. Comparison of recovery effect for sufentanil and remifentanil anesthesia with TCI in laparoscopic radical resection during colorectal cancer. Oncol Lett. 2016;11(5):3361-3365. doi:10.3892/ol.2016.4394
Liang H, Yang CX, Zhang B, et al. Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α. J Anesth. 2015;29(6):821-830. doi:10.1007/s00540-015-2035-7
Ecimovic P, Mchugh B, Murray D, Doran P, Buggy DJ. Effects of sevoflurane on breast cancer cell function in vitro. Anticancer Res. 2013;33(10):4255-4260. doi:10.1097/00003643-201006121-00001
Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth. 2009;103(5):685-690. doi:10.1093/bja/aep261
Ferrell JK, Cattano D, Brown RE, Patel CB, Karni RJ. The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: A pilot study. Transl Res. 2015;166(6):674-682. doi:10.1016/j.trsl.2015.09.001
Huang H, Benzonana LL, Zhao H, et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014;111(7):1338-1349. doi:10.1038/bjc.2014.426
Luo X, Zhao H, Hennah L, et al. Impact of is of lurane on malignant capability of ovarian cancer in vitro. Br J Anaesth. 2015;114(5):831-839. doi:10.1093/bja/aeu408
Caveolins LA, Murray F, Ph D, et al. Volatile Anesthetics Protect Cancer Cells against Tumor Necrosis Factor-related Apoptosis-inducing. 2011;(September).
Moudgil GC, Gordon J, Forrest JB. Comparative effects of volatile anaesthetic agents and nitrous oxide on human leucocyte chemotaxis in vitro. Can Anaesth Soc J. 1984;31(6):631-637. doi:10.1007/BF03008758
Hatzoglou A, Bakogeorgou E, Castanas E. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol. 1996;296(2):199-207. doi:10.1016/0014-2999(95)00703-2
Tegeder I. Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications. Pharmacol Rev. 2004;56(3):351-369. doi:10.1124/pr.56.3.2
Lin X, Wang YJ, Li Q, et al. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J. 2009;276(7):2022-2036. doi:10.1111/j.1742-4658.2009.06938.x
Tegeder I, Grösch S, Schmidtko A, et al. G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: Involvement of p53 phosphorylation. Cancer Res. 2003;63(8):1846-1852.
Gach K, Szemraj J, Wyrȩbska A, Janecka A. The influence of opioids on matrix metalloproteinase-2 and-9 secretion and mRNA levels in MCF-7 breast cancer cell line. Mol Biol Rep. 2011;38(2):1231-1236. doi:10.1007/s11033-010-0222-z
Singleton PA, Mirzapoiazova T, Hasina R, Salgia R, Moss J. Increased μ-opioid receptor expression in metastatic lung cancer. Br J Anaesth. 2014;113(SUPPL. 1):1-6. doi:10.1093/bja/aeu165
Lennon Frances E. PD, Mirzapoiazova Ph.D., Tamara MD, Mambetsariev Bolot PD, Salgia Ph.D., Ravi MD, Moss Ph.D., Jonathan MD, Singleton Patrick A. PD. Overexpression of the μ-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis. Anesthesiology. 2012;116(4):857-867. http://dx.doi.org/10.1097/ALN.0b013e31824babe2.
Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: A laboratory investigation. Anesth Analg. 2011;112(3):558-567. doi:10.1213/ANE.0b013e31820568af
Lennon FE, Mirzapoiazova T, Mambetsariev B, et al. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One. 2014;9(3):1-13. doi:10.1371/journal.pone.0091577
Singleton PA, Lingen MW, Fekete MJ, Garcia JGN, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: Role of receptor transactivation. Microvasc Res. 2006;72(1-2):3-11. doi:10.1016/j.mvr.2006.04.004
Singleton PA, Moss J. Cancer Recurrence : a Hypothesis. 2010:1237-1242
Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 2002;62(15):4491-4498
Bimonte S, Barbieri A, Rea D, et al. Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression. Biomed Res Int. 2015;2015. doi:10.1155/2015/161508
Leo S, Nuydens R, Meert TF. Opioid-induced proliferation of vascular endothelial cells. J Pain Res. 2009;2:59-66. doi:10.1300/J426v02n04
Page GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC. Morphine attenuates surgeryinduced enhancement of metastatic colonization in rats. Pain. 1993;54(1):21-28. doi:10.1016/0304-3959(93)90095-7
Page GG, Mcdonald JS, Ben-Eliyahu S. Pre-operative versus postoperative administration of morphine: Impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth. 1998;81(2):216-223. doi:10.1093/bja/81.2.216
Cata JP, Keerty V, Keerty D, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med. 2014;3(4):900-908. doi:10.1002/cam4.236
Li AX, Xin WQ, Ma CG. Fentanyl inhibits the invasion and migration of colorectal cancer cells via inhibiting the negative regulation of Ets-1 on BANCR. Biochem Biophys Res Commun. 2015;465(3):594-600. doi:10.1016/j.bbrc.2015.08.068
Zhang XL, Chen ML, Zhou SL. Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin. Int J Clin Exp Pathol. 2015;8(1):227-235.
Bundscherer A, Malsy M, Gebhardt K, et al. Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro. Pharmacol Res. 2015;95-96:126-131. doi:10.1016/j.phrs.2015.03.017
Juneja R. Opioids and cancer recurrence. Curr Opin Support Palliat Care. 2014;8(2):91-101. doi:10.1097/SPC.0000000000000056
Xu L, Stevens J, Hilton MB, et al. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Transl Med. 2014;6(242). doi:10.1126/scitranslmed.3008455
Harris RE, Beebe-Donk J, Alshafie GA. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer. 2006;6:1-5. doi:10.1186/1471-2407-6-27
Retsky M, Rogers R, Demicheli R, et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012;134(2):881-888. doi:10.1007/s10549-012-2094-5
Tseng JH, Cowan RA, Afonso AM, et al. Gynecologic Oncology Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2018;151(2):287-293. doi:10.1016/j.ygyno.2018.08.024
Soltanizadeh S, Degett TH, Gögenur I. Journal of Clinical Anesthesia Outcomes of cancer surgery after inhalational and intravenous anesthesia : A systematic review. J Clin Anesth. 2017;42:19-25. doi:10.1016/j.jclinane.2017.08.001
Corcoran T, Paech M, Law D, Muchatuta NA, French M, Ho KM. Intraoperative dexamethasone alters immune cell populations in patients undergoing elective laparoscopic gynaecological surgery. Br J Anaesth. 2017;119(2):221-230. doi:10.1093/bja/aex154
Hiller JG, Ismail HM, Hofman MS, Narayan K, Ramdave S, Riedel BJ. Neuraxial Anesthesia Reduces Lymphatic Flow. Anesth Analg. 2016;123(5):1325-1327. doi:10.1213/ane.0000000000001562
Kim SY, Kim NK, Baik SH, et al. Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer: A randomized study. Med (United States). 2016;95(19):1-8. doi:10.1097/MD.0000000000003602
Zhou L, Li Y, Li X, et al. Propranolol Attenuates Surgical Stress–Induced Elevation of the Regulatory T Cell Response in Patients Undergoing Radical Mastectomy. J Immunol. 2016;196(8):3460-3469. doi:10.4049/jimmunol.1501677
Tedore T. Regional anaesthesia and analgesia: Relationship to cancer recurrence and survival. Br J Anaesth. 2015;115:ii34-ii45. doi:10.1093/bja/aev375
Bakr MA-E-M, Amr SA-ER, Mohamed SA, et al. Comparison Between the Effects of Intravenous Morphine, Tramadol, and Ketorolac on Stress and Immune Responses in Patients Undergoing Modified Radical Mastectomy. Clin J Pain. 2016;32(10):889-897. doi:10.1097/AJP.0000000000000338
Heaney Á, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth. 2012;109(SUPPL1):17-28. doi:10.1093/bja/aes421
Conrick-Martin I, Kell MR, Buggy DJ. Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function. J Clin Anesth. 2012;24(1):3-7. doi:10.1016/j.jclinane.2011.09.001
Gottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth. 2012;109(2):253-259. doi:10.1093/bja/aes176
Papadima A, Boutsikou M, Lagoudianakis EE, et al. Lymphocyte apoptosis after major abdominal surgery is not influenced by anesthetic technique: a comparative study of general anesthesia versus combined general and epidural analgesia. J Clin Anesth. 2009;21(6):414-421. doi:10.1016/j.jclinane.2008.10.015
Lim J, Oh C, Yoon T, et al. The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery : an in vitro analysis. 2018:1-8.
Liu S, Gu X, Zhu L, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Medicine (Baltimore). 2016;95(49):e5479. doi:10.1097/MD.0000000000005479
Woo JH, Baik HJ, Kim CH, et al. Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial. @BULLET J Korean Med Sci. 2015;30(19):1503-1508. doi:10.3346/jkms.2015.30.10.1503
Ren XF, Li WZ, Meng FY, Lin CF. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. 2010:478-482. doi:10.1111/j.1365-2044.2010.06304.x
Han X, Wen X, Li Y, et al. Effect of different anesthetic methods on cellular immune functioning and the prognosis of patients with ovarian cancer undergoing oophorectomy. 2017;0:1-11.
Xu Q, Shi N, Zhang H, Zhu Y. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with nonsmall cell lung cancer: A comparative study. Mol Med Rep. 2017;(21):4445-4454. doi:10.3892/mmr.2017.714
Desmond F, Mccormack J, Mulligan N, Stokes M, Buggy DJ. Effect of Anaesthetic Technique on Immune Cell Infiltration in Breast Cancer : A Follow-up Pilot Analysis of a Prospective, Randomised, Investigator-masked Study. 2015;1320:1311-1319.
Buckley A, McQuaid S, Johnson P, Buggy DJ. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: A pilot study. Br J Anaesth. 2014;113(SUPPL. 1):i56-i62. doi:10.1093/bja/aeu200
Xu YJ, Chen WK, Zhu Y, Wang SL, Miao CH. Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer. 2014;113(June):49-55. doi:10.1093/bja/aeu148
Cata JP, Gottumukkala V, Thakar D, Keerty D, Gebhardt R, Liu DD. Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer. J Clin Anesth. 2014;26(1):3-17. doi:10.1016/j.jclinane.2013.06.007
Zhou D, Gu F, Gao Q, Li Q, Zhou J, Miao C. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy. 2012;18(24):3089-3098. doi:10.3748/wjg.v18.24.3089
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Byrne K, Levins KJ, Buggy DJ. Les techniques d’anesthésie et d’analgésie lors d’une chirurgie de cancer primitif peuvent-elle affecter la récurrence ou la métastase? Can J Anesth. 2016;63(2):184-192. doi:10.1007/s12630-015-0523-8
Shapiro J, Jersky J, Katzav S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest. 1981;68(3):678-685. doi:10.1172/JCI110303
Puig N, Colluci D, Hernandez-Pando R. Influence of anaesthetic drugs on immune response: from inflammation to immunosuppression. OA Anaesth. 2013;1(3):21. https://www.oapublishinglondon.com/article/1091.
Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of Natural Killer Cell Activity and Promotion of Tumor Metastasis by Ketamine, Thiopental, and Halothane, but Not by Propofol: Mediating Mechanisms and Prophylactic Measures. Anesth Analg. 2003;97(5):1331-1339. doi:10.1213/01.ANE.0000082995.44040.07
Cho JS, Lee M-H, Kim S Il, et al. The Effects of Perioperative Anesthesia and Analgesia on Immune Function in Patients Undergoing Breast Cancer Resection: A Prospective Randomized Study. Int J Med Sci. 2017;14(10):970-976. doi:10.7150/ijms.20064
Al-Hasani R, Bruchas MR. Molecular Mechanisms of Opioid Receptor-Dependent Signalling and Behaviour. Anesthesiology. 2011;115(6):1363-1381. doi:10.1097/ALN.0b013e318238bba6.Molecular
Chen WK, Ren L, Wei Y, Zhu DX, Miao CH, Xu JM. General anesthesia combined with epidural anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression and facilitating intestinal functional recovery in colon cancer patients. Int J Colorectal Dis. 2015;30(4):475-481. doi:10.1007/s00384-014-2098-1
Borner C, Warnick B, Smida M, et al. Mechanisms of Opioid-Mediated Inhibition of Human T Cell Receptor Signaling. J Immunol. 2009;183(2):882-889. doi:10.4049/jimmunol.0802763
Wang J, Barke RA, Charboneau R, Loh HH, Roy S. Morphine negatively regulates interferon-γ promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem. 2003;278(39):37622-37631. doi:10.1074/jbc.M301224200
Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008;22(3):263-277. doi:10.1007/s00540-008-0626-2
Zhou Y, Li E, Li Y, Liu S. Attenuating sevoflurane-induced cellular injury of human peripheral lymphocytes by propofol in a concentration-dependent manner. Arch Pharm Res. 2011;34(9):1535-1543. doi:10.1007/s12272-011-0916-3
Wei H, Xie Z. Anesthesia, calcium homeostasis and Alzheimer’s disease. Curr Alzheimer Res. 2009;6(1):30-35. doi:10.2174/156720509787313934
Braz MG, Magalhães MR, Salvadori DM, et al. Evaluation of DNA damage and lipoperoxidation of propofol in patients undergoing elective surgery. Eur J Anaesthesiol. 2009;26(8):654-660. doi:10.1097/EJA.0b013e328329b12c
Rizzo MT. Cyclooxygenase-2 in oncogenesis. Clin Chim Acta. 2011;412(9-10):671-687. doi:10.1016/j.cca.2010.12.026
Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol. 2007;29(3-4):477-486. doi:10.1080/08923970701675085
Pirbudak Cocelli L, Ugur MG, Karadasli H. Comparison of Effects of Low-Flow Sevoflurane and Desflurane Anesthesia on Neutrophil and T-Cell Populations. Curr Ther Res-Clin Exp. 2012;73(1-2):41-51. doi:10.1016/j.curtheres.2012.02.005
Benish M, Bartal I, Goldfarb Y, et al. Perioperative use of β-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15(7):2042-2052. doi:10.1245/s10434-008-9890-5
Glasner A, Avraham R, Rosenne E, et al. Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor. J Immunol. 2010;184(5):2449-2457. doi:10.4049/jimmunol.0903301
Wang X, Liang Y, Wang J, Wang M. Effect of NS-398, a cyclooxygenase-2 selective inhibitor, on the cytotoxicity of cytotoxic T lymphocytes to ovarian carcinoma cells. Tumor Biol. 2013;34(3):1517-1522. doi:10.1007/s13277-013-0677-3
Veltman JD, Lambers MEH, van Nimwegen M, et al. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BMC Cancer. 2010;10:1-13. doi:10.1186/1471-2407-10-464
Lönnroth C, Andersson M, Arvidsson A, et al. Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer. Cancer Immun. 2008;8(February):1-10. doi:080206 [pii]
Ramirez MF, Tran P, Cata JP. The effect of clinically therapeutic plasma concentrations of lidocaine on natural killer cell cytotoxicity. Reg Anesth Pain Med. 2015;40(1):43-48. doi:10.1097/AAP.0000000000000191
Das J, Kumar S, Khanna S, Mehta Y. Are we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practice. J Anaesthesiol Clin Pharmacol. 2014;30(2):153. doi:10.4103/0970-9185.129996
Sacerdote P, Bianchi M, Gaspani L, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 2000;90(6):1411-1414. doi:10.1097/00000539-200006000-00028
Qi Y, Yao X, Zhang B, Du X. Comparison of recovery effect for sufentanil and remifentanil anesthesia with TCI in laparoscopic radical resection during colorectal cancer. Oncol Lett. 2016;11(5):3361-3365. doi:10.3892/ol.2016.4394
Liang H, Yang CX, Zhang B, et al. Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α. J Anesth. 2015;29(6):821-830. doi:10.1007/s00540-015-2035-7
Ecimovic P, Mchugh B, Murray D, Doran P, Buggy DJ. Effects of sevoflurane on breast cancer cell function in vitro. Anticancer Res. 2013;33(10):4255-4260. doi:10.1097/00003643-201006121-00001
Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth. 2009;103(5):685-690. doi:10.1093/bja/aep261
Ferrell JK, Cattano D, Brown RE, Patel CB, Karni RJ. The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: A pilot study. Transl Res. 2015;166(6):674-682. doi:10.1016/j.trsl.2015.09.001
Huang H, Benzonana LL, Zhao H, et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014;111(7):1338-1349. doi:10.1038/bjc.2014.426
Luo X, Zhao H, Hennah L, et al. Impact of is of lurane on malignant capability of ovarian cancer in vitro. Br J Anaesth. 2015;114(5):831-839. doi:10.1093/bja/aeu408
Caveolins LA, Murray F, Ph D, et al. Volatile Anesthetics Protect Cancer Cells against Tumor Necrosis Factor-related Apoptosis-inducing. 2011;(September).
Moudgil GC, Gordon J, Forrest JB. Comparative effects of volatile anaesthetic agents and nitrous oxide on human leucocyte chemotaxis in vitro. Can Anaesth Soc J. 1984;31(6):631-637. doi:10.1007/BF03008758
Hatzoglou A, Bakogeorgou E, Castanas E. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol. 1996;296(2):199-207. doi:10.1016/0014-2999(95)00703-2
Tegeder I. Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications. Pharmacol Rev. 2004;56(3):351-369. doi:10.1124/pr.56.3.2
Lin X, Wang YJ, Li Q, et al. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J. 2009;276(7):2022-2036. doi:10.1111/j.1742-4658.2009.06938.x
Tegeder I, Grösch S, Schmidtko A, et al. G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: Involvement of p53 phosphorylation. Cancer Res. 2003;63(8):1846-1852.
Gach K, Szemraj J, Wyrȩbska A, Janecka A. The influence of opioids on matrix metalloproteinase-2 and-9 secretion and mRNA levels in MCF-7 breast cancer cell line. Mol Biol Rep. 2011;38(2):1231-1236. doi:10.1007/s11033-010-0222-z
Singleton PA, Mirzapoiazova T, Hasina R, Salgia R, Moss J. Increased μ-opioid receptor expression in metastatic lung cancer. Br J Anaesth. 2014;113(SUPPL. 1):1-6. doi:10.1093/bja/aeu165
Lennon Frances E. PD, Mirzapoiazova Ph.D., Tamara MD, Mambetsariev Bolot PD, Salgia Ph.D., Ravi MD, Moss Ph.D., Jonathan MD, Singleton Patrick A. PD. Overexpression of the μ-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis. Anesthesiology. 2012;116(4):857-867. http://dx.doi.org/10.1097/ALN.0b013e31824babe2.
Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: A laboratory investigation. Anesth Analg. 2011;112(3):558-567. doi:10.1213/ANE.0b013e31820568af
Lennon FE, Mirzapoiazova T, Mambetsariev B, et al. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One. 2014;9(3):1-13. doi:10.1371/journal.pone.0091577
Singleton PA, Lingen MW, Fekete MJ, Garcia JGN, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: Role of receptor transactivation. Microvasc Res. 2006;72(1-2):3-11. doi:10.1016/j.mvr.2006.04.004
Singleton PA, Moss J. Cancer Recurrence : a Hypothesis. 2010:1237-1242
Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 2002;62(15):4491-4498
Bimonte S, Barbieri A, Rea D, et al. Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression. Biomed Res Int. 2015;2015. doi:10.1155/2015/161508
Leo S, Nuydens R, Meert TF. Opioid-induced proliferation of vascular endothelial cells. J Pain Res. 2009;2:59-66. doi:10.1300/J426v02n04
Page GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC. Morphine attenuates surgeryinduced enhancement of metastatic colonization in rats. Pain. 1993;54(1):21-28. doi:10.1016/0304-3959(93)90095-7
Page GG, Mcdonald JS, Ben-Eliyahu S. Pre-operative versus postoperative administration of morphine: Impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth. 1998;81(2):216-223. doi:10.1093/bja/81.2.216
Cata JP, Keerty V, Keerty D, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med. 2014;3(4):900-908. doi:10.1002/cam4.236
Li AX, Xin WQ, Ma CG. Fentanyl inhibits the invasion and migration of colorectal cancer cells via inhibiting the negative regulation of Ets-1 on BANCR. Biochem Biophys Res Commun. 2015;465(3):594-600. doi:10.1016/j.bbrc.2015.08.068
Zhang XL, Chen ML, Zhou SL. Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin. Int J Clin Exp Pathol. 2015;8(1):227-235.
Bundscherer A, Malsy M, Gebhardt K, et al. Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro. Pharmacol Res. 2015;95-96:126-131. doi:10.1016/j.phrs.2015.03.017
Juneja R. Opioids and cancer recurrence. Curr Opin Support Palliat Care. 2014;8(2):91-101. doi:10.1097/SPC.0000000000000056
Xu L, Stevens J, Hilton MB, et al. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Transl Med. 2014;6(242). doi:10.1126/scitranslmed.3008455
Harris RE, Beebe-Donk J, Alshafie GA. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer. 2006;6:1-5. doi:10.1186/1471-2407-6-27
Retsky M, Rogers R, Demicheli R, et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012;134(2):881-888. doi:10.1007/s10549-012-2094-5
Tseng JH, Cowan RA, Afonso AM, et al. Gynecologic Oncology Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2018;151(2):287-293. doi:10.1016/j.ygyno.2018.08.024
Soltanizadeh S, Degett TH, Gögenur I. Journal of Clinical Anesthesia Outcomes of cancer surgery after inhalational and intravenous anesthesia : A systematic review. J Clin Anesth. 2017;42:19-25. doi:10.1016/j.jclinane.2017.08.001
Corcoran T, Paech M, Law D, Muchatuta NA, French M, Ho KM. Intraoperative dexamethasone alters immune cell populations in patients undergoing elective laparoscopic gynaecological surgery. Br J Anaesth. 2017;119(2):221-230. doi:10.1093/bja/aex154
Hiller JG, Ismail HM, Hofman MS, Narayan K, Ramdave S, Riedel BJ. Neuraxial Anesthesia Reduces Lymphatic Flow. Anesth Analg. 2016;123(5):1325-1327. doi:10.1213/ane.0000000000001562
Kim SY, Kim NK, Baik SH, et al. Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer: A randomized study. Med (United States). 2016;95(19):1-8. doi:10.1097/MD.0000000000003602
Zhou L, Li Y, Li X, et al. Propranolol Attenuates Surgical Stress–Induced Elevation of the Regulatory T Cell Response in Patients Undergoing Radical Mastectomy. J Immunol. 2016;196(8):3460-3469. doi:10.4049/jimmunol.1501677
Tedore T. Regional anaesthesia and analgesia: Relationship to cancer recurrence and survival. Br J Anaesth. 2015;115:ii34-ii45. doi:10.1093/bja/aev375
Bakr MA-E-M, Amr SA-ER, Mohamed SA, et al. Comparison Between the Effects of Intravenous Morphine, Tramadol, and Ketorolac on Stress and Immune Responses in Patients Undergoing Modified Radical Mastectomy. Clin J Pain. 2016;32(10):889-897. doi:10.1097/AJP.0000000000000338
Heaney Á, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth. 2012;109(SUPPL1):17-28. doi:10.1093/bja/aes421
Conrick-Martin I, Kell MR, Buggy DJ. Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function. J Clin Anesth. 2012;24(1):3-7. doi:10.1016/j.jclinane.2011.09.001
Gottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth. 2012;109(2):253-259. doi:10.1093/bja/aes176
Papadima A, Boutsikou M, Lagoudianakis EE, et al. Lymphocyte apoptosis after major abdominal surgery is not influenced by anesthetic technique: a comparative study of general anesthesia versus combined general and epidural analgesia. J Clin Anesth. 2009;21(6):414-421. doi:10.1016/j.jclinane.2008.10.015
Lim J, Oh C, Yoon T, et al. The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery : an in vitro analysis. 2018:1-8.
Liu S, Gu X, Zhu L, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Medicine (Baltimore). 2016;95(49):e5479. doi:10.1097/MD.0000000000005479
Woo JH, Baik HJ, Kim CH, et al. Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial. @BULLET J Korean Med Sci. 2015;30(19):1503-1508. doi:10.3346/jkms.2015.30.10.1503
Ren XF, Li WZ, Meng FY, Lin CF. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. 2010:478-482. doi:10.1111/j.1365-2044.2010.06304.x
Han X, Wen X, Li Y, et al. Effect of different anesthetic methods on cellular immune functioning and the prognosis of patients with ovarian cancer undergoing oophorectomy. 2017;0:1-11.
Xu Q, Shi N, Zhang H, Zhu Y. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with nonsmall cell lung cancer: A comparative study. Mol Med Rep. 2017;(21):4445-4454. doi:10.3892/mmr.2017.714
Desmond F, Mccormack J, Mulligan N, Stokes M, Buggy DJ. Effect of Anaesthetic Technique on Immune Cell Infiltration in Breast Cancer : A Follow-up Pilot Analysis of a Prospective, Randomised, Investigator-masked Study. 2015;1320:1311-1319.
Buckley A, McQuaid S, Johnson P, Buggy DJ. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: A pilot study. Br J Anaesth. 2014;113(SUPPL. 1):i56-i62. doi:10.1093/bja/aeu200
Xu YJ, Chen WK, Zhu Y, Wang SL, Miao CH. Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer. 2014;113(June):49-55. doi:10.1093/bja/aeu148
Cata JP, Gottumukkala V, Thakar D, Keerty D, Gebhardt R, Liu DD. Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer. J Clin Anesth. 2014;26(1):3-17. doi:10.1016/j.jclinane.2013.06.007
Zhou D, Gu F, Gao Q, Li Q, Zhou J, Miao C. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy. 2012;18(24):3089-3098. doi:10.3748/wjg.v18.24.3089
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
El cáncer es una de las patologías de mayor aumento de morbimortalidad a nivel mundial, siendo el manejo quirúrgico uno de los pilares fundamentales para su tratamiento, en donde el acto anestésico cada vez cobra más relevancia, se ha planteado
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65cc5454f15b8180df74deb99a3e550d
http://repository.urosario.edu.co/handle/10336/20024
http://repository.urosario.edu.co/handle/10336/20024
